Different allergenic activity of grass pollen allergens revealed by skin testing

European Journal of Clinical Investigation

Volumn 38, Issue 4, 2008, Pages 260-267

  Westritschnig, K ^a,c   Horak, F ^a   Swoboda, I ^a   Balic, N ^a   Spitzauer, S ^a   Kundi, M ^a,d   Fiebig, H ^b   Suck, R ^b   Cromwell, O ^b   Valenta, R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ALLERGOPHARMA JOACHIM GANZER KG   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

^d Medical University of Vienna   (Austria)

Author keywords

Allergenic activity; Grass pollen allergy; Human; Immunotherapy; Recombinant allergen; Skin prick test

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; PHL P 1 ALLERGEN; PHL P 2 ALLERGEN; PHL P 5 ALLERGEN; PHL P 6 ALLERGEN; UNCLASSIFIED DRUG;

ADULT; ALLERGENICITY; ANTIBODY TITER; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; FEMALE; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLLEN ALLERGY; PRICK TEST; PRIORITY JOURNAL; SKIN TEST;

ADULT; ALLERGENS; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOLOGIC FACTORS; MALE; PHLEUM; POLLEN; SKIN TESTS;

EID: 40749148537     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2008.01938.x     Document Type: Article

References (38)

1. Wuthrich B, Schindler C, Leuenberger P, Ackermann-Liebrich U. Prevalence of atopy and pollinosis in the adult population of Switzerland (SAPALDIA study). Swiss Study on Air Pollution and Lung Diseases in Adults. Int Arch Allergy Immunol 1995 106:149 56.
2. Larche M, Akdis CA, Valenta R. Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006 6:761 71.
3. Valenta R, Niederberger V. Recombinant allergens for immunotherapy. J Allergy Clin Immunol 2007 119:826 30.
4. Valenta R, Kraft D. From allergen structure to new forms of allergen-specific immunotherapy. Curr Opin Immunol 2002 14:718 27.
5. Van Hage-Hamsten M, Pauli G. Provocation testing with recombinant allergens. Methods 2004 32:281 91.
6. Schmidt-Grendelmeier P, Crameri R. Recombinant allergens for skin testing. Int Arch Allergy Immunol 2001 125:96 111.
7. Astier C, Morisset M, Roitel O, Codreanu F, Jacquenet S, Franck P et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol 2006 118:250 6.
8. 2LEN project. Allergy 2006 61:671 80.
9. Esch RE. Grass pollen allergens. Clin Allergy Immunol 2004 18:185 205.
10. Andersson K, Lidholm J. Characteristics and immunobiology of grass pollen allergens. Int Arch Allergy Immunol, 2003 130:87 107.
11. Laffer S, Valenta R, Vrtala S, Susani M, van Ree R, Kraft D et al. Complementary DNA cloning of the major allergen Phl p 1 from timothy grass (Phleum pratense): recombinant Phl p 1 inhibits IgE binding to group 1 allergens from eight different grass species. J Allergy Clin Immunol 1994 94:689 98.
12. Laffer S, Spitzauer S, Susani M, Pairleitner H, Schweiger C, Grönlund H et al. Comparison of recombinant timothy grass pollen allergens with natural extract for diagnosis of grass pollen allergy in different populations. J Allergy Clin Immunol 1996 98:652 8.
13. Niederberger V, Laffer S, Froschl R, Kraft D, Rumpold H, Kapiotis S et al. IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE. J Allergy Clin Immunol 1998 101:258 64.
14. Heiss S, Mahler V, Steiner R, Spitzauer S, Schweiger C, Kraft D et al. Component-resolved diagnosis (CRD) of type I allergy with recombinant grass and tree pollen allergens by skin testing. J Invest Dermatol 1999 113:830 7.
15. Niederberger V, Stubner P, Spitzauer S, Kraft D, Valenta R, Ehrenberger K et al. Skin test results but not serology reflect immediate type respiratory sensitivity: a study performed with recombinant allergen molecules. J Invest Dermatol 2001 117:848 51.
16. Dolecek C, Vrtala S, Laffer S, Steinberger P, Kraft D, Scheiner O et al. Molecular characterization of Phl p 2, a major timothy grass (Phleum pratense) pollen allergen. FEBS Lett 1993 335:299 304.
17. Vrtala S, Sperr WR, Reimitzer I, van Ree R, Laffer S, Muller WD et al. cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl p 5 allergen. J Immunol 1993 151:4773 9.
18. Petersen A, Bufe A, Schramm G, Schlaak M, Becker WM. Characterization of the allergen group VI in timothy grass pollen (Phl p 6). II. cDNA cloning of Phl p 6 and structural comparison to grass group V. Int Arch Allergy Immunol 1995 108:55 9.
19. Vrtala S, Fischer S, Grote M, Vangelista L, Pastore A, Sperr WR et al. Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from Timothy grass (Phleum pratense) pollen. J Immunol 1999 163:5489 96.
20. Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005 116:608 13.
21. Stumvoll S, Lidholm J, Thunberg R, DeWitt AM, Eibensteiner P, Swoboda I et al. Purification, structural and immunological characterization of a timothy grass (Phleum pratense) pollen allergen, Phl p 4, with cross-reactive potential. Biol Chem 2002 383:1383 96.
22. Suck R, Hagen S, Cromwell O, Fiebig H. The high molecular mass allergen fraction of timothy grass pollen (Phleum pratense) between 50 and 60 kDa is comprised of two major allergens: Phl p 4 and Phl p 13. Clin Exp Allergy 2000 30:1395 402.
23. Nandy A, Petersen A, Wald M, Suck R, Kahlert H, Weber B et al. Primary structure, recombinant expression, and molecular characterization of Phl p 4, a major allergen of timothy grass (Phleum pratense). Biochem Biophys Res Commun 2005 337:563 70.
24. Dewitt AM, Andersson K, Peltre G, Lidholm J. Cloning, expression and immunological characterization of full-length timothy grass pollen allergen Phl p 4, a berberine bridge enzyme-like protein with homology to celery allergen Api g 5. Clin Exp Allergy 2006 36:77 86.
25. Swoboda I, Grote M, Verdino P, Keller W, Singh MB, De Weerd N et al. Molecular characterization of polygalacturonases as grass pollen-specific marker allergens: expulsion from pollen via submicronic respirable particles. J Immunol 2004 172:6490 500.
26. Grote M, Swoboda I, Valenta R, Reichelt R. Group 13 allergens as environmental and immunological markers for grass pollen allergy: studies by immunogold field emission scanning and transmission electron microscopy. Int Arch Allergy Immunol 2005 136:303 10.
27. Niederberger V, Ring J, Rakoski J, Jäger S, Spitzauer S, Valent P et al. Antigens drive memory IgE responses in human allergy via the nasal mucosa. Int Arch Allergy Immunol 2007 142:133 42.
28. Suck R, Kamionka T, Schaeffer B, Wahl R, Nandy A, Weber B et al. Bacterially expressed and optimized recombinant Phl p 1 is immunobiochemically equivalent to natural Phl p 1. Biochim Biophys Acta 2006 1764:1701 9.
29. Cromwell O, Suck R, Kahlert H, Nandy A, Weber B, Fiebig H. Transition of recombinant allergens from bench to clinical application. Methods 2004 32:300 12.
30. Vrtala S, Susani M, Sperr WR, Valent P, Laffer S, Dolecek C et al. Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p 2, Phl p 5). Allergy Clin Immunol 1996 97:781 7.
31. Purohit A, Laffer S, Metz-Vavre C, Verot A, Kricek E, Valenta R, Pauli G. Poor association between allergen-specific serum immunoglobulin E levels, skin sensitivity and basophil degranulation: a study with recombinant birch pollen allergen Bet v 1 and an immunoglobulin E detection system measuring immunoglobulin E capable of binding to Fc epsilon RI. Clin Exp Allergy 2005 35:186 92.
32. Fernandez-Rivas M, Brewczynski PZ, Kroon AM, van Ree R. A clinical trial with purified natural major allergens from grass pollen. Arb Paul Ehrich Inst Bundesamt Sera Impfstoffe Frankf A M 1999:131 6.
33. Niederberger V, Horak F, Vrtala S, Spitzauer S, Krauth MT, Valent P et al. Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci USA 2004 101:14677 82.
34. Simons FE, Shikishima Y, Van Nest G, Eiden JJ, HayGlass KT. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J Allergy Clin Immunol 2004 113:1144 51.
35. Tulic MK, Fiset PO, Christodoulopoulos P, Vaillancourt P, Desrosiers M, Lavigne F et al. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol 2004 113:235 41.
36. Linhart B, Valenta R. Molecular design of allergy vaccines. Curr Opin Immunol 2005 17:646 55.
37. Pree I, Reisinger J, Focke M, Vrtala S, Pauli G, van Hage M et al. Analysis of epitope-specific immune responses induced vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man. J Immunol 2007 179:5309 16.
38. Kleine-Tebbe J, Erdmann S, Knol EF, MacGlashan DW Jr., Poulsen LK, Gibbs BF. Diagnostic tests based on human basophils: potentials, pitfalls and perspectives. Int Arch Allergy Immunol 2006 141:79 90.